Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 21, 2014
Pharmacy Choice - Pharmaceutical News - Main Line Health Doctor Urges Discussion About Colon Cancer Treatment During Colorectal Health Month - September 21, 2014

Pharmacy News Article

 3/18/14 - Main Line Health Doctor Urges Discussion About Colon Cancer Treatment During Colorectal Health Month

By a News Reporter-Staff News Editor at Cancer Weekly Colorectal cancer is the second leading cause of cancer deaths among men and women in the U.S. Faced with these daunting facts, Dr. John Marks, Chief of Colorectal Surgery at Main Line Health and Director of the Mirable Colorectal Cancer Center at Lankenau Medical Center wants Americans to have candid conversations about treatment so they are better prepared should they or loved ones develop this common and deadly cancer (see also Main Line Health).

"Many people are talking about colorectal cancer prevention, which is great. But too few people are talking about treatment options," says John Marks, M.D., Lankenau Medical Center, Main Line Health. "Let's take the stigma away from learning about treatment so that more people aren't afraid to talk about these problems and can have access to the new technology and microsurgeries that can save lives and preserve bowel function."

Under his leadership at Lankenau, a part of Main Line Health, 90-95 percent of colorectal surgeries are performed laparoscopically. The sphincter preservation rate for this approach, which eliminates the need for a colostomy bag, is 93 percent at Lankenau vs. 40-60 percent for the national average. This statistic is encouraging for patients facing colorectal cancer diagnosis. Traditionally for many patients with colorectal cancer, treatment means the loss of the sphincter and the prospect of a life with a colostomy bag. This makes people afraid to even get checked.

Dr. Marks has set the global standard of care for colorectal treatment. Outcome data shows the recurrence rate of cancer at Lankenau is 2.3 percent vs. a 10-25 percent national average and the hospital's survival rate is 88 percent compared to 68 percent nationally. Dr. Marks' presentation on his approach was recently named the best session at an American College of Surgeons meeting.

Keywords for this news article include: Hospital, Oncology, Treatment, Gastroenterology, Main Line Health.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC



(c) 2014 Cancer Weekly via NewsRx.com

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Sep 22: A Patient-Centered Approach to Chronic Pain Management
Last Chance
Sep 23: On the Move: A Comprehensive Review of Osteoarthritis, Gout & Rheumatoid Arthritis
Sep 24: Drug Recalls, Alerts and Reasons
Sep 25: Antibiotic Resistance: From Threat to Reality
Sep 26: Pharmacy Malpractice Case Studies
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415